PIRAS, Sandra
 Distribuzione geografica
Continente #
NA - Nord America 26.143
AS - Asia 2.763
SA - Sud America 1.870
EU - Europa 1.765
AF - Africa 121
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 10
Totale 32.684
Nazione #
US - Stati Uniti d'America 26.009
BR - Brasile 1.664
SG - Singapore 1.153
CN - Cina 775
UA - Ucraina 486
IT - Italia 440
HK - Hong Kong 259
DE - Germania 235
SE - Svezia 144
VN - Vietnam 144
FI - Finlandia 98
GB - Regno Unito 94
AR - Argentina 89
TR - Turchia 66
IN - India 59
CA - Canada 53
RU - Federazione Russa 51
BD - Bangladesh 45
MX - Messico 44
IQ - Iraq 37
BE - Belgio 35
FR - Francia 35
ZA - Sudafrica 33
PK - Pakistan 30
PL - Polonia 29
EC - Ecuador 28
CO - Colombia 26
MA - Marocco 26
KR - Corea 25
NL - Olanda 25
JP - Giappone 22
UZ - Uzbekistan 22
VE - Venezuela 20
KE - Kenya 18
CZ - Repubblica Ceca 16
JO - Giordania 16
AE - Emirati Arabi Uniti 15
IR - Iran 15
PY - Paraguay 13
ID - Indonesia 11
NP - Nepal 11
ES - Italia 10
IE - Irlanda 10
AU - Australia 9
DZ - Algeria 9
EG - Egitto 9
LT - Lituania 9
PE - Perù 9
SA - Arabia Saudita 9
AZ - Azerbaigian 8
CL - Cile 8
TN - Tunisia 8
AT - Austria 7
BG - Bulgaria 7
IL - Israele 7
JM - Giamaica 7
KZ - Kazakistan 7
OM - Oman 7
PA - Panama 7
EU - Europa 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
RO - Romania 5
RS - Serbia 5
TT - Trinidad e Tobago 5
AL - Albania 4
BO - Bolivia 4
CI - Costa d'Avorio 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CR - Costa Rica 3
GY - Guiana 3
KG - Kirghizistan 3
NG - Nigeria 3
NI - Nicaragua 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BN - Brunei Darussalam 2
HN - Honduras 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
PS - Palestinian Territory 2
SM - San Marino 2
AM - Armenia 1
BH - Bahrain 1
CH - Svizzera 1
CU - Cuba 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
HR - Croazia 1
HU - Ungheria 1
Totale 32.670
Città #
Dallas 22.924
Singapore 632
Chandler 631
Jacksonville 287
Hong Kong 252
Ashburn 231
Beijing 177
Princeton 176
New York 170
Nanjing 131
São Paulo 115
Dearborn 107
Ann Arbor 92
Sassari 86
Los Angeles 71
Wilmington 69
Ho Chi Minh City 58
Shanghai 56
Belo Horizonte 55
Nanchang 55
Rio de Janeiro 50
Boardman 49
Munich 35
Santa Clara 35
Brasília 32
Brussels 30
Woodbridge 30
Hanoi 29
Changsha 28
Shenyang 28
Warsaw 27
Tianjin 26
Hebei 25
Seoul 25
Baghdad 24
Buenos Aires 24
Campinas 24
Denver 24
Mountain View 24
Cagliari 23
Johannesburg 23
Jinan 22
Helsinki 21
Jiaxing 21
Montreal 21
Rome 21
Tashkent 21
Curitiba 20
Porto Alegre 20
The Dalles 20
Tokyo 20
Chennai 19
Council Bluffs 18
Salvador 18
San Francisco 18
Brooklyn 17
London 17
Poplar 17
Buffalo 16
Chicago 16
Columbus 16
Goiânia 16
Milan 16
Santo André 16
Andover 15
Mumbai 15
Nairobi 15
Toronto 15
Amman 14
Atlanta 14
Boston 14
Brno 14
Izmir 14
Orem 14
Dhaka 13
Guangzhou 13
Manaus 13
Mexico City 13
Haikou 12
Asunción 11
Augusta 11
Caxias do Sul 11
Stockholm 11
Betim 10
Dublin 10
Frankfurt am Main 10
Naples 10
Ribeirão Preto 10
Sorocaba 10
São José dos Campos 10
West Jordan 10
Barbianello 9
Bogotá 9
Carapicuíba 9
Casablanca 9
Da Nang 9
Feira de Santana 9
Franca 9
Guarulhos 9
Haiphong 9
Totale 27.830
Nome #
[1,2,3]triazolo[4,5-H]chinoloni: una nuova classe di promettenti chemioterapici antitubercolari 10.305
[1,2,3]triazolo[4,5-H]chinoloni: una nuova classe di promettenti chemioterapici antitubercolari 10.259
Synthesis of Novel Tricyclic N-Acylhydrazones as Tubulin Polymerization Inhibitors 446
Nuovi derivati chinossalinici inibitori della Diidrofolato Reduttasi (DHFR) e della Timidilato Sintetasi (TS) dellaLeishmania major: risultati preliminari 295
Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor Activity 273
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 233
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 226
Design and synthesis of novel FGFR inhibitors for the treatment of glioblastoma 224
1H,6H-triazolo[4,5-e]benzotriazole-3-oxides and 5,5’-(Z)-diazene-1,2-diylbis(2-methyl-2H-1,2,3-benzotriazole) derived from chloronitrobenzotriazoles and hydrazine 223
2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7trifluoromethylquinoxalines as anticancer agents Inhibitors of folate enzymes 209
Benzotriazole: an overview on its versatile biological behaviour 206
A comprehensive assessment of a new series of 5′,6′-difluorobenzotriazole-acrylonitrile derivatives as microtubule targeting agents (MTAs) 181
A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems 177
Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase 170
5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus 169
Enhancement of antimicrobial activity of pump inhibitors associating drugs 168
Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives 165
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: A novel classo f potent tubulin inhibitors 161
Anti-mycobacterial activity of quinolones. Triazoloquinolones a new class of potent anti mycobacterial agents 152
Anti-BVDV Activity Evaluation of Naphthoimidazole Derivatives Compared with Parental Imidazoquinoline Compounds 146
Design, Synthesis, and Antiviral Activities of New Benzotriazole-Based Derivatives 145
4,7-FENANTROLINE: UNA NUOVA CLASSE DI INIBITORI DELLA POLIMERASI DI RNA-VIRUS 145
2(3)-Aryl-thio(oxy)-methylquinoxaline Derivatives: A New Class of P-Glycoprotein-Mediated Drug Efflux Inhibitors 145
Design, synthesis, and biological screening of a series of 4′-fluoro-benzotriazole-acrylonitrile derivatives as microtubule-destabilising agents (MDAs) 142
Antiviral activities of 5-chlorobenzotriazole derivatives 138
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development 137
Antibiotics and Carbohydrate-Containing Drugs Targeting Bacterial Cell Envelopes: An Overview 135
E-3-aril-(1H-benzotriazol-1-il)acrilonitrili: una nuova classe di inibitori della tubulina ad attività antitumorale 133
Development of folates analogs against folate-dependent enzymes 133
Synthesis of 2-(Quinoxalin-2-ylamino-benzotriazolyl) Pentanedioic Derivatives as Potential Anti-Folate Agents 133
Inhibition of Enterovirus A71 by a Novel 2-Phenyl-Benzimidazole Derivative 132
Synthesis and anti-mycobacterial activities of triazoloquinolones 132
Synthesis and antiviral activity of new phenylimidazopyridines and N-benzylidenequinolinamines derived by molecular simplification of phenylimidazo[4,5-g]quinolines 132
Manuale di analisi farmaceutica. Analisi organica qualitativa non strumentale 128
Preliminary anti-coxsackie activity of novel 1-[4-(5,6-dimethyl(h)1h(2h)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas 128
Solid Lipid Nanoparticles as Formulative Strategy to Increase Oral Permeation of a Molecule Active in Multidrug-Resistant Tuberculosis Management 124
Quinoline tricyclic derivatives. Design, synthesis and preliminary in vitro and in silico antiviral activity against flaviridae family of three new classes of virus encoded RNA- dependent polymerase(RdRp). In: Book of Abstracts 124
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. . 124
Antiviral activity of benzotriazole based derivatives 122
Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells 122
Quinoxaline chemistry.Part 6 Synthesis and evaluation of antiulcer and gastroproctetive activity of 2-[arylmethylmercapto-,arylmethylsulfinyl-,piperazinyl-3-R-substituted]quinoxalines 119
SAR and Anti-Mycobacterial Activity of Quinolones and Triazoloquinolones: An Update 118
Analisi Qualitativa Farmaceutica 118
Development of oxygen-bridged pyrazole-based structures as cannabinoid receptor 1 ligands 118
Activity and molecular modeling of a new small molecule active against NNRTI-resistant HIV-1 mutants 118
Inhibition of RNA Helicase of ssRNA+ virus belonging to Flaviviridae, Coronaviridae and Picornaviridae families 115
Improving in vivo oral bioavailability of a poorly soluble drug: a case study on polymeric versus lipid nanoparticles 113
Benzimidazole-2-Phenyl-Carboxamides as Dual-Target Inhibitors of BVDV Entry and Replication 110
Quinoxaline chemistry. Part 6- Synthesis and evaluation of antiulcer and gastroprotective activity of 2 –[arylmethylmercapto- arylmethylsulfinyl- piperazinyl- 3- r- substitute] quinoxalines. 109
Novel N-aryl nicotinamide derivatives: tacking stock on 3,6-diazabicyclo[3.3.1]heptanes as ligands for neuronal acetylcholine receptors 109
Synthesis, Antitumor and Antiviral In Vitro Activities of New Benzotriazole-Dicarboxamide Derivatives 108
Reaction of 5-aminobenzotriazoles with methyl propiolate. Formation of triazolo[4,5-f]quinolines and related compounds. Unusual products in the Michael addition reaction of 2-methyl-2H-5-aminobenzotriazole 106
Quinoxaline derivatives as new inhibitors of coxsackievirus B5 106
Triazolopyridinyl-acrylonitrile derivatives as antimicrotubule agents: synthesis, in vitro and in silico characterization of antiproliferative activity, inhibition of tubulin polymerization and binding thermodynamics 105
Dichloro-phenyl -benzotriazoles: a new selective class of human respiratory syncytial virus entry inhibitors 105
Benzoyl-piperazinil chinossaline come potenziali antitumorali 103
Phytochemical compositions and biological activities of essential oils from the leaves, rhizomes and whole plant of hornstedtia bella Škorničk 102
Synthesis and anti-picornaviridae in vitro activity of a new class of helicase inhibitors the N,N'-bis[4-(1H(2H)-benzotriazol-1(2)-yl)fenyl]alkyldicarboxamides 102
Quinoxaline chemistry. Part 15.4-[2-quinoxalylmethylenimino]-benzoylglutamates and benzoates, 4-[2-quinoxalylmethyl-N-methylamino]-benzoylglutamates as analogues of classical antifolate agents. Synthesis, elucidation of structures and in vitro evaluation of antifolate and anticancer activities 101
Reactions Of Alkylation Of Biologically Interesting Triazolo[4,5-g]Quinolines And Triazolo[4,5-g]Quinoline-1-Oxides With Electrophilic Reagents 100
Human Enterovirus B: Selective Inhibition by Quinoxaline Derivatives and Bioinformatic RNA-Motif Identification as New Targets 97
Synthesis and evaluation of gastroprotective activity of omeprazole related benzimidazole, imidazo(4,5-b)pyridine and quinoxaline 2-substituted derivatives 97
Quinoxaline Chemistry. Part 17. 4[3,6(7) disubstituted-2-quinoxalinyl-oxa]phenylacetate and phenylacetylglutamate analogues of methotrexate: Synthesis and evaluation of in vitro anticancer activity 96
Analisi Farmaceutica Qualitativa 94
Manuale di analisi qualitativa. Con e-book. EDISES 93
Quinoxaline analogues-homologues of methotrexate 92
quinoxaline chemistry.Part 7. 2-[aminobenzoates]-and2-[aminobenzoylglutamate]-quinoxalines as classical antifolate agents. Sinthesis and evaluation of in vitro anticancer, anti- HIV and antifungal activity 92
Synthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides 92
Synthesis and evaluation of gastroprotective and antiulcer of some 2-substituted- 1H- imidazo[4,5-b]pyridines and 1H- benzimidazoles. 92
Chemistry, biological properties and SAR analysis of quinoxalinones 90
Benzotriazolilfenilalchilammidi. Una nuova classe di inibitori delle RNA elicasi di virus a singola catena a RNA a genoma positivo e negativo 90
Synthesis and evaluation of gastroprotective and antiulcer activity of some 2- substituted-1H-imidazo[4,5-b] pyridines and -1H-benzimidazoles 89
Ligand-based virtual screening and ADME-tox guided approach to identify triazolo-quinoxalines as folate cycle inhibitors 89
Chasing the evaders. Design, Synthesis, Activity, and Molecular Modeling of a New Small Molecule with Activity Against Drug-Resistant HIV-1 mutants 88
Quinoxaline chemistry. Part 14. 4-(2-quinoxalylamino)-phenylacetates and 4-(2-quinoxalylamino)-phenylacetyl-L-glutamates as analogues-homologues of classical antifolate agents. Synthesis and evaluation of in vitro anticancer activity 88
Synthesis and biological evaluation of novel indole-derived thioureas 88
Sintesi di nuove 6,7-diamminochinoline quali intermedi per la preparazione di molecole ad attività biologica 87
Sinthesis and evaluation of gastroproctetive activity of omeprazole related benzimidazole,imidazo[4,5-b]pyridine and quinoxaline 2-substituted derivatives 86
Novel 3-benzoyl-2-piperazinylquinoxaline derivatives as potential antitumor agents 86
Quinoline triciclic derivatives. Design, synthesis and preliminary in vitro and in silico antiviral activity against flaviviridae family of three new classes of viruses-encoded RNA-dependent RNA polymerase (RdRp) inhibitors 85
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and antileukemia evaluation 84
Triazolochinoloni. Una nuova classe di agenti antitubercolari attivi su ceppi MDR di M. tuberculosis 81
Synthesis and in vitro evaluation of the antiviral activity of a series of novel N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides 78
Quinoline tricyclic derivatives. Design, synthesis and evaluation of the antiviral activity of three new classes of RNA-Dependent RNA Polymerase inhibitors 78
Discovery of pyridoquinoxaline-based new P-gp inhibitors as coadjutant against Multi Drug Resistance in cancer 77
Synthesis and evaluation of antiulcer and gastroprotective activity of 2-[arylmethylmercapto-, arylmethylsulfinyl-, piperazinyl-3-r-substituted] quinoxalines 73
Synthesis of linear azolo and pyrido quinolines from quinoline derivatives 73
Synthesis and in vitro anticancer evaluatio of variously substituted 3- phenoxymethyl quinoxalin-2-ones and quinoxalines in combination with various drugs against kb mdr tumor cells 73
E-3-aril-2-(1H-benzotriazol-1-il)acrilonitrili: una nuova classe di inibitori della tubulina ad attività antitumorale 73
Systhesis and evaluation of gastroprotective activity of omeprazole imidazo(4,5-b) pyridine and quinoxaline 2- substituted derivatives. 72
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development 69
Quinoline tricyclic derivatives. Design, synthesis and preliminary in vitro and in silico antiviral activity against flaviviridae family of three new classes of virus-encoded RNA-dependent RNA polymerase (RdRp) inhibitors 69
Sintesi di nuove 6,7- diamminochinoline quali intermedi per la preparazione di molecole ad attività biologica 68
Helicase inhibitors as anti-RNA virus agents 67
Novel quinoxaline analogues as inhibitors of folate enzimes 66
Sintesi di una nuova serie di N-[4-(1H(2H)-benzotriazol-1(2)-il)fenil]alchilcarbossiammidi e N,N'-bis[4-(1H(2H)-benzotriazol-1(2)-il)fenil]alchildicarbossiammidi a potenziale attività antivirale 65
Sintesi di una nuova serie di n-[4-(1H(2H)-benzotriazol-1(2)- il)fenil]alchilcarbossiammidi e n,n'-bis[4-(1H(2H)-benzotriazol- 1(2)-il)fenil]alchildicarbossiammidi a potenziale attività antivirale 65
nuovi derivari chinossalinici inibitori della diidrofolato reduttasi (DHFR) e della timidilato sintetasi (TS) della leishmania major: risultati preliminari 63
Quinoxaline analogues-homologues of classical antifolates 62
Sintesi ed attività antiulcera di 2-arilmetilmercapto-, 2-solfinilarilchinossaline 62
Totale 32.456
Categoria #
all - tutte 66.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.245


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021408 0 0 0 0 0 26 87 16 96 98 69 16
2021/2022501 67 2 5 12 6 11 16 30 51 51 61 189
2022/20231.232 105 101 31 206 98 193 14 157 198 20 66 43
2023/2024510 56 24 17 12 76 122 10 30 1 19 59 84
2024/20253.398 29 33 155 111 101 72 277 653 1.097 567 189 114
2025/202625.202 332 6.419 16.603 1.076 507 265 0 0 0 0 0 0
Totale 32.785